Literature DB >> 34268603

Bis(triazinyl)pyridine complexes of Pt(II) and Pd(II): studies of the nucleophilic substitution reactions, DNA/HSA interactions, molecular docking and biological activity.

Snežana Jovanović-Stević1, Snežana Radisavljević2, Andreas Scheurer3, Dušan Ćoćić2, Biljana Šmit4, Marijana Petković5, Marko N Živanović4, Katarina Virijević4, Biljana Petrović2.   

Abstract

Four new complexes of Pt(II) and Pd(II), [Pd(L1)Cl]Cl 1, [Pd(L2)Cl]Cl 2, [Pt(L1)Cl]Cl 3 and [Pt(L2)Cl]Cl 4 (where L1 = 2,6-bis(5,6-diphenyl-1,2,4-triazin-3-yl)pyridine and L2 = 2,6-bis(5,6-dipropyl-1,2,4-triazin-3-yl)pyridine), were synthesized. Characterization of the complexes was performed using elemental analysis, IR, 1H NMR spectroscopy and MALDI-TOF mass spectrometry. The substitution reactions of 1-4 complexes with L-methionine (L-met), L-cysteine (L-cys) and guanosine-5'-monophosphate (5'-GMP), were studied spectrophotometrically at physiological conditions. Complexes with ligand L1 (1 or 3) were more reactive than those with ligand L2 (2 or 4) by a factor ranging up to 1.57 and 3.71, respectively. The order of reactivity of the nucleophiles was: L-met > L-cys > 5'-GMP. The interactions of complexes with calf thymus-DNA (CT-DNA) and human serum albumin (HSA) were studied by Uv-Vis absorption and fluorescence emission spectroscopy. Competitive binding studies with intercalative agent ethidium bromide (EB) and minor groove binder Hoechst 33258 were performed as well. All studied complexes can interact with DNA through the intercalation and minor groove binding, where the latter was preferred. The binding constants (103 and 104 M-1) for the interaction of complexes with HSA indicate the moderate binding affinity of complexes 1-4 to protein. The trends in the experimental results of binding studies between complexes 3 and 4 with DNA and HSA were compared to those obtained from the molecular docking study. Biological evaluation of cytotoxicity of 1 and 2 on HCT-116 and MDA-MB-231 cell lines showed significant cytotoxic and prooxidative character, while 2 also exerted extraordinary selectivity towards colon cancer in comparison to breast cancer cells. The nucleophilic substitution reactions, DNA/HSA interactions, molecular docking and biological activity of bis(triazinyl)pyridine complexes of Pt(II) and Pd(II) were studied.
© 2021. Society for Biological Inorganic Chemistry (SBIC).

Entities:  

Keywords:  Bis(triazinyl)pyridine; Cytotoxicity; DNA/HSA interaction; Kinetics; Molecular docking; Pd(II)/Pt(II) complexes; Redox status

Year:  2021        PMID: 34268603     DOI: 10.1007/s00775-021-01879-3

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  26 in total

1.  New bimetallic palladium(ii) and platinum(ii) complexes: studies of the nucleophilic substitution reactions, interactions with CT-DNA, bovine serum albumin and cytotoxic activity.

Authors:  Snežana Jovanović; Katarina Obrenčević; Živadin D Bugarčić; Iva Popović; Jelena Žakula; Biljana Petrović
Journal:  Dalton Trans       Date:  2016-08-02       Impact factor: 4.390

2.  In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.

Authors:  Milos Arsenijevic; Marija Milovanovic; Snezana Jovanovic; Natalija Arsenijevic; Bojana Simovic Markovic; Marina Gazdic; Vladislav Volarevic
Journal:  J Biol Inorg Chem       Date:  2017-04-18       Impact factor: 3.358

3.  Role of π-acceptor effects in controlling the lability of novel monofunctional Pt(II) and Pd(II) complexes: crystal structure of [Pt(tripyridinedimethane)Cl]Cl.

Authors:  Biljana Petrović; Živadin D Bugarčić; Anne Dees; Ivana Ivanović-Burmazović; Frank W Heinemann; Ralph Puchta; Stephan N Steinmann; Clemence Corminboeuf; Rudi van Eldik
Journal:  Inorg Chem       Date:  2012-01-20       Impact factor: 5.165

Review 4.  Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.

Authors:  Živadin D Bugarčić; Jovana Bogojeski; Biljana Petrović; Stephanie Hochreuther; Rudi van Eldik
Journal:  Dalton Trans       Date:  2012-10-28       Impact factor: 4.390

Review 5.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

6.  Homo- and hetero-dinuclear Pt(II)/Pd(II) complexes: studies of hydrolysis, nucleophilic substitution reactions, DNA/BSA interactions, DFT calculations, molecular docking and cytotoxic activity.

Authors:  Dušan Ćoćić; SneŽana Jovanović-Stević; Ratomir Jelić; Sanja Matić; Suzana Popović; Predrag Djurdjević; Dejan Baskić; Biljana Petrović
Journal:  Dalton Trans       Date:  2020-10-27       Impact factor: 4.390

7.  New monofunctional platinum(II) and palladium(II) complexes: Studies of the nucleophilic substitution reactions, DNA/BSA interaction, and cytotoxic activity.

Authors:  Dušan Ćoćić; Snežana Jovanović; Snežana Radisavljević; Jana Korzekwa; Andreas Scheurer; Ralph Puchta; Dejan Baskić; Danijela Todorović; Suzana Popović; Sanja Matić; Biljana Petrović
Journal:  J Inorg Biochem       Date:  2018-09-17       Impact factor: 4.155

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 9.  Metal complexes in cancer therapy - an update from drug design perspective.

Authors:  Umar Ndagi; Ndumiso Mhlongo; Mahmoud E Soliman
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

Review 10.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.